Accro Bioscience to Present Phase II Data of AC-201 for Plaque Psoriasis at the European Academy of Dermatology & Venereology Congress 2025 in Paris
NEW YORK and SUZHOU, China, Sept. 4, 2025 /PRNewswire/ -- Accro Bioscience (Accropeutics), a clinical-stage biotech company focused on molecular mechanisms of regulated cell death and related pathogenesis in human diseases, today announced that it will present results from a Phase II clinical study evaluating AC-201, an oral, selective TYK2/JAK1 Inhibitor, in moderate-to-severe plaque psoriasis, at the European Academy of...
Angel Yeast Protein Receives U.S. GRAS Certification, Opening the Door to Broader Access to Sustainable Protein
SHANGHAI, Sept. 4, 2025 /PRNewswire/ -- Angel Yeast (SH600298), a leading global provider of yeast and fermentation-based ingredients, announced today that its proprietary yeast protein, AngeoPro, has been granted Generally Recognized as Safe (GRAS) status by the U.S. Food and Drug Administration (FDA). Angel Yeast Protein Receives U.S....
Halia Therapeutics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
LEHI, Utah, Sept. 4, 2025 /PRNewswire/ -- Halia Therapeutics, Inc., a clinical-stage biopharmaceutical company developing first-in-class anti-inflammatory therapies, today announced that the Company plans to participate in the Morgan Stanley 23rd Annual Global Healthcare Conference. Jared Bearss, Chief Operating Officer of Halia, will provide a business overview presentation on Tuesday, September 9,...
Sentec Receives FDA Clearance for LuMon™ Electrical Impedance Tomography (EIT) System — First EIT System Indicated for Premature Infants and for Spontaneously Breathing Patients in the United States
The LuMon™ System is also CE-marked under EU MDR and registered with TGA in Australia. LINCOLN, R.I., Sept. 4, 2025 /PRNewswire/ -- Sentec, a global leader in non-invasive patient monitoring, announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its LuMon™ Electrical Impedance Tomography (EIT) system...
Waterdrop Inc. Announces Second Quarter 2025 Unaudited Financial Results and a Cash Dividend
BEIJING, Sept. 4, 2025 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced its unaudited financial results for the three and six months ended June 30, 2025 and a cash dividend. Financial and Operational Highlights for the Second Quarter of 2025 Further...
4DMedical’s CT:VQ™ receives FDA 510(k) clearance; First-and-only CT-based VQ technology
Medicare confirms reimbursement, unlocking nationwide access to non-contrast ventilation–perfusion imaging from routine chest CT LOS ANGELES, Sept. 4, 2025 /PRNewswire/ -- 4DMedical, a leader in advanced respiratory imaging, today announces U.S. Food and Drug Administration (FDA) 510(k) clearance for CT:VQ™, the world's first and only non-contrast, ventilation–perfusion (VQ) imaging solution. In parallel, the U.S....
UNSW and NeuRA Lead New Study to Explore How ReNeuWell® App Supports Mental Wellbeing
SYDNEY, Sept. 4, 2025 /PRNewswire/ -- A clinical trial is being launched by researchers from UNSW and Neuroscience Research Australian (NeuRA) for a new app called ReNeuWell®, based on a scientifically validated measure of wellbeing. UNSW and NeuRA launch ReNeuWell® app, applying psychology and neuroscience to support adult mental health. The application has been...
Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development
Illumina Protein Prep can measure 9500 unique human protein targets, offering new insights into protein biology to fuel novel discovery for treatment of disease Following early access program, customers commend scale, high consistency, and easy sample to insights workflow Launch follows Illumina's announcement of agreement to acquire SomaLogic SAN DIEGO, Sept. 3, 2025 /PRNewswire/ -- Illumina Inc. (NASDAQ:...
Global Bio Conference 2025 kicks off in Seoul, charting biotech’s future
SEOUL, South Korea, Sept. 3, 2025 /PRNewswire/ -- This is an article published in The Korea Herald: The Ministry of Food and Drug Safety announced Wednesday that it kicked off Global Bio Conference 2025, under the theme "Bio, Navigating Infinite Possibilities." The conference will be held from Wednesday to Friday at the Grand InterContinental Seoul Parnas in southern Seoul....
Acer Expands SpatialLabs Pro Ecosystem with Immersive 3D Capabilities Across Multiple Verticals
Editor's Summary Integration with NVIDIA Omniverse libraries via OpenXR runtime supports enhanced spatial awareness for industrial designs and simulations Partnership with Video Engineering brings 3D stereo microscopy to inspection, design, and prototyping workflows Collaboration with Smart Surgery for medical training allows for high-resolution, glasses-free analysis on SpatialLabs' 3D displays BERLIN,...
